Financial - Capital Markets
Compare Stocks
2 / 10Stock Comparison
TW vs CME
Revenue, margins, valuation, and 5-year total return — side by side.
Financial - Data & Stock Exchanges
TW vs CME — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Financial - Capital Markets | Financial - Data & Stock Exchanges |
| Market Cap | $23.49B | $104.06B |
| Revenue (TTM) | $2.05B | $6.52B |
| Net Income (TTM) | $870M | $4.24B |
| Gross Margin | 67.3% | 86.1% |
| Operating Margin | 41.2% | 64.9% |
| Forward P/E | 27.3x | 23.5x |
| Total Debt | $278M | $3.76B |
| Cash & Equiv. | $2.08B | $4.42B |
TW vs CME — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Tradeweb Markets In… (TW) | 100 | 167.1 | +67.1% |
| CME Group Inc. (CME) | 100 | 157.1 | +57.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: TW vs CME
Each card shows where this stock fits in a portfolio — not just who wins on paper.
TW is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 18.9%, EPS growth 61.5%
- Lower volatility, beta 0.09, Low D/E 3.9%, current ratio 4.94x
- PEG 0.81 vs CME's 1.71
CME carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 6 yrs, beta -0.30, yield 3.8%
- 289.3% 10Y total return vs TW's 215.0%
- Beta -0.30, yield 3.8%, current ratio 92.97x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 18.9% NII/revenue growth vs CME's 6.4% | |
| Value | PEG 0.81 vs 1.71 | |
| Quality / Margins | Efficiency ratio 0.2% vs TW's 0.3% (lower = leaner) | |
| Stability / Safety | Lower D/E ratio (3.9% vs 13.1%) | |
| Dividends | 3.8% yield, 6-year raise streak, vs TW's 0.4% | |
| Momentum (1Y) | +5.5% vs TW's -23.3% | |
| Efficiency (ROA) | Efficiency ratio 0.2% vs TW's 0.3% |
TW vs CME — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
TW vs CME — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CME leads this category, winning 4 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
CME is the larger business by revenue, generating $6.5B annually — 3.2x TW's $2.1B. CME is the more profitable business, keeping 62.0% of every revenue dollar as net income compared to TW's 39.6%.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $2.1B | $6.5B |
| EBITDAEarnings before interest/tax | $1.2B | $4.7B |
| Net IncomeAfter-tax profit | $870M | $4.2B |
| Free Cash FlowCash after capex | $1.1B | $4.4B |
| Gross MarginGross profit ÷ Revenue | +67.3% | +86.1% |
| Operating MarginEBIT ÷ Revenue | +41.2% | +64.9% |
| Net MarginNet income ÷ Revenue | +39.6% | +62.0% |
| FCF MarginFCF ÷ Revenue | +54.9% | +64.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +39.1% | +21.4% |
Valuation Metrics
TW leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 25.7x trailing earnings, CME trades at a 12% valuation discount to TW's 29.2x P/E. Adjusting for growth (PEG ratio), TW offers better value at 0.86x vs CME's 1.87x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||
|---|---|---|
| Market CapShares × price | $23.5B | $104.1B |
| Enterprise ValueMkt cap + debt − cash | $21.7B | $103.4B |
| Trailing P/EPrice ÷ TTM EPS | 29.16x | 25.70x |
| Forward P/EPrice ÷ next-FY EPS est. | 27.28x | 23.49x |
| PEG RatioP/E ÷ EPS growth rate | 0.86x | 1.87x |
| EV / EBITDAEnterprise value multiple | 19.79x | 22.95x |
| Price / SalesMarket cap ÷ Revenue | 11.44x | 15.96x |
| Price / BookPrice ÷ Book value/share | 3.29x | 3.60x |
| Price / FCFMarket cap ÷ FCF | 20.84x | 24.81x |
Profitability & Efficiency
TW leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
CME delivers a 15.3% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $12 for TW. TW carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to CME's 0.13x. On the Piotroski fundamental quality scale (0–9), TW scores 8/9 vs CME's 5/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +12.4% | +15.3% |
| ROA (TTM)Return on assets | +10.7% | +2.2% |
| ROICReturn on invested capital | +9.1% | +10.2% |
| ROCEReturn on capital employed | +11.6% | +3.6% |
| Piotroski ScoreFundamental quality 0–9 | 8 | 5 |
| Debt / EquityFinancial leverage | 0.04x | 0.13x |
| Net DebtTotal debt minus cash | -$1.8B | -$666M |
| Cash & Equiv.Liquid assets | $2.1B | $4.4B |
| Total DebtShort + long-term debt | $278M | $3.8B |
| Interest CoverageEBIT ÷ Interest expense | 636.14x | 41.55x |
Total Returns (Dividends Reinvested)
CME leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CME five years ago would be worth $16,437 today (with dividends reinvested), compared to $13,654 for TW. Over the past 12 months, CME leads with a +5.5% total return vs TW's -23.3%. The 3-year compound annual growth rate (CAGR) favors CME at 19.8% vs TW's 15.8% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +3.9% | +9.1% |
| 1-Year ReturnPast 12 months | -23.3% | +5.5% |
| 3-Year ReturnCumulative with dividends | +55.2% | +71.9% |
| 5-Year ReturnCumulative with dividends | +36.5% | +64.4% |
| 10-Year ReturnCumulative with dividends | +215.0% | +289.3% |
| CAGR (3Y)Annualised 3-year return | +15.8% | +19.8% |
Risk & Volatility
CME leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CME is the less volatile stock with a -0.30 beta — it tends to amplify market swings less than TW's 0.09 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CME currently trades 87.1% from its 52-week high vs TW's 73.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.09x | -0.30x |
| 52-Week HighHighest price in past year | $149.25 | $329.16 |
| 52-Week LowLowest price in past year | $97.06 | $257.17 |
| % of 52W HighCurrent price vs 52-week peak | +73.8% | +87.1% |
| RSI (14)Momentum oscillator 0–100 | 41.2 | 46.0 |
| Avg Volume (50D)Average daily shares traded | 1.3M | 2.2M |
Analyst Outlook
CME leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates TW as "Buy" and CME as "Hold". Consensus price targets imply 18.1% upside for TW (target: $130) vs 11.7% for CME (target: $320). For income investors, CME offers the higher dividend yield at 3.81% vs TW's 0.43%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold |
| Price TargetConsensus 12-month target | $130.20 | $320.25 |
| # AnalystsCovering analysts | 28 | 35 |
| Dividend YieldAnnual dividend ÷ price | +0.4% | +3.8% |
| Dividend StreakConsecutive years of raises | 5 | 6 |
| Dividend / ShareAnnual DPS | $0.48 | $10.92 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.4% | +0.3% |
CME leads in 4 of 6 categories (Income & Cash Flow, Total Returns). TW leads in 2 (Valuation Metrics, Profitability & Efficiency).
TW vs CME: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is TW or CME a better buy right now?
For growth investors, Tradeweb Markets Inc.
(TW) is the stronger pick with 18. 9% revenue growth year-over-year, versus 6. 4% for CME Group Inc. (CME). CME Group Inc. (CME) offers the better valuation at 25. 7x trailing P/E (23. 5x forward), making it the more compelling value choice. Analysts rate Tradeweb Markets Inc. (TW) a "Buy" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — TW or CME?
On trailing P/E, CME Group Inc.
(CME) is the cheapest at 25. 7x versus Tradeweb Markets Inc. at 29. 2x. On forward P/E, CME Group Inc. is actually cheaper at 23. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Tradeweb Markets Inc. wins at 0. 81x versus CME Group Inc. 's 1. 71x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — TW or CME?
Over the past 5 years, CME Group Inc.
(CME) delivered a total return of +64. 4%, compared to +36. 5% for Tradeweb Markets Inc. (TW). Over 10 years, the gap is even starker: CME returned +289. 3% versus TW's +215. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — TW or CME?
By beta (market sensitivity over 5 years), CME Group Inc.
(CME) is the lower-risk stock at -0. 30β versus Tradeweb Markets Inc. 's 0. 09β — meaning TW is approximately -130% more volatile than CME relative to the S&P 500. On balance sheet safety, Tradeweb Markets Inc. (TW) carries a lower debt/equity ratio of 4% versus 13% for CME Group Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — TW or CME?
By revenue growth (latest reported year), Tradeweb Markets Inc.
(TW) is pulling ahead at 18. 9% versus 6. 4% for CME Group Inc. (CME). On earnings-per-share growth, the picture is similar: Tradeweb Markets Inc. grew EPS 61. 5% year-over-year, compared to 15. 4% for CME Group Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — TW or CME?
CME Group Inc.
(CME) is the more profitable company, earning 62. 0% net margin versus 39. 6% for Tradeweb Markets Inc. — meaning it keeps 62. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CME leads at 64. 9% versus 41. 2% for TW. At the gross margin level — before operating expenses — CME leads at 86. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is TW or CME more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Tradeweb Markets Inc. (TW) is the more undervalued stock at a PEG of 0. 81x versus CME Group Inc. 's 1. 71x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, CME Group Inc. (CME) trades at 23. 5x forward P/E versus 27. 3x for Tradeweb Markets Inc. — 3. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for TW: 18. 1% to $130. 20.
08Which pays a better dividend — TW or CME?
All stocks in this comparison pay dividends.
CME Group Inc. (CME) offers the highest yield at 3. 8%, versus 0. 4% for Tradeweb Markets Inc. (TW).
09Is TW or CME better for a retirement portfolio?
For long-horizon retirement investors, CME Group Inc.
(CME) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 30), 3. 8% yield, +289. 3% 10Y return). Both have compounded well over 10 years (CME: +289. 3%, TW: +215. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between TW and CME?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: TW is a mid-cap high-growth stock; CME is a mid-cap income-oriented stock. CME pays a dividend while TW does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.